Company Filing History:
Years Active: 2024
Title: Shahab Mortezaei: Innovator in Pharmaceutical Chemistry
Introduction
Shahab Mortezaei is a notable inventor based in Santa Clara, CA. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical treatments. His work focuses on innovative solutions for complex health issues.
Latest Patents
Shahab Mortezaei holds a patent for "Pyrimidines for degrading Bruton's tyrosine kinase." This invention provides compounds of formula (I), wherein R, R, R, R, R, and R are defined, along with pharmaceutically acceptable salts. These compounds are useful as agents in the treatment of Chronic Lymphocytic Leukemia (CLL). He has 1 patent to his name.
Career Highlights
Shahab Mortezaei is currently employed at AbbVie Inc., a leading biopharmaceutical company. His role involves research and development aimed at creating effective treatments for various diseases. His expertise in pharmaceutical chemistry has positioned him as a valuable asset in his field.
Collaborations
Some of his notable coworkers include Zhiguo Bian and Jason P Burke. Their collaborative efforts contribute to the advancement of innovative treatments in the pharmaceutical industry.
Conclusion
Shahab Mortezaei is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of serious health conditions. His contributions, particularly in the area of CLL treatment, highlight the importance of innovation in medicine.